Source:http://linkedlifedata.com/resource/pubmed/id/15191381
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2004-6-11
|
pubmed:abstractText |
To determine the sensitivity and specificity of Focus HerpeSelect ELISAs, sera or plasma samples from women aged 18-55 years were collected in ten cities from eight countries and tested by HerpeSelect HSV-1 ELISA (Focus-HSV-1) and by HerpeSelect HSV-2 ELISA (Focus-HSV-2). Sera with Focus-HSV-2-positive results were retested; 94% of the 3617 samples retested were positive. A subset of sera from each site was then selected, based on the HSV-2 results, and tested by Western blot (WB). The sensitivity and specificity were determined with samples from ten sites (n = 967) for Focus-HSV-1 and from seven sites (n = 675) for Focus-HSV-2. Focus-HSV-1 and WB results were concordant (both negative or both positive) for 97% of samples, with 99% sensitivity and 77% specificity. Specimens from Songkla, Thailand had 84% concordance with WB results for HSV-1, while three other sites had 100% concordance. Concordance of Focus-HSV-2 and WB was 92%, with 97% sensitivity and 89% specificity. Ibadan, Nigeria had 78% concordance. Focus-HSV-2 sensitivity and specificity in sites other than Ibadan were 97% and 93%, respectively. Raising the positive cut-off index value for HSV-2 from 1.1 to 3.5 yielded a sensitivity of 90% and a specificity of 96%. A sensitivity of 90% and a specificity of 98% were achieved for sites other than Nigeria with the higher cut-off. In summary, the sensitivity and specificity of the Focus-HSV-1 and Focus-HSV-2 tests varied by site. Performance data generated in one area may not be applicable to other populations.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1198-743X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
530-6
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15191381-Adolescent,
pubmed-meshheading:15191381-Adult,
pubmed-meshheading:15191381-Antibodies, Viral,
pubmed-meshheading:15191381-Blotting, Western,
pubmed-meshheading:15191381-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:15191381-Female,
pubmed-meshheading:15191381-Herpes Genitalis,
pubmed-meshheading:15191381-Herpes Simplex,
pubmed-meshheading:15191381-Herpesvirus 1, Human,
pubmed-meshheading:15191381-Herpesvirus 2, Human,
pubmed-meshheading:15191381-Humans,
pubmed-meshheading:15191381-Internationality,
pubmed-meshheading:15191381-Middle Aged,
pubmed-meshheading:15191381-Reagent Kits, Diagnostic,
pubmed-meshheading:15191381-Reproducibility of Results,
pubmed-meshheading:15191381-Sensitivity and Specificity
|
pubmed:year |
2004
|
pubmed:articleTitle |
Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations.
|
pubmed:affiliation |
Department of Laboratory Medicine, University of Washington, Seattle, Washington 98105, USA. rhoda.morrow@seattlechildrens.org
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|